Initially developed for diabetes care, Semaglutide gained widespread recognition for its ability to assist patients in achieving significant health milestones, from better glycemic control to effective weight reduction
Due to this androgen-dependent alteration in insulin sensitivity, women with PCOS frequently exhibit compensatory hyperinsulinemia
Venn BJ 1 , Green TJ, Moser R, McKenzie JE, Skeaff CM, Mann J
Preclinical studies confirmed that adding glucagon activity helps counteract the bodys adaptive slowing of metabolism during weight loss [7]
Coadministration with any other product containing lixisenatide or another glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended [see Warnings and Precautions (5.5)]
These psychological adjustments require recognition and, where appropriate, professional support